| PD-1在肝细胞癌肿瘤浸润淋巴细胞中的表达及与预后的相关性 |
| |
| 引用本文： | 肖 锋,肖静文,邵建国,陈丽燕,顾春燕. PD-1在肝细胞癌肿瘤浸润淋巴细胞中的表达及与预后的相关性[J]. 中国癌症杂志, 2021, 31(5): 419-427. DOI: 10.19401/j.cnki.1007-3639.2021.05.008 |
| |
| 作者姓名： | 肖 锋 肖静文 邵建国 陈丽燕 顾春燕 |
| |
| 作者单位： | 1. 南通大学附属南通第三医院，南通市第三人民医院病理科，江苏 南通 226006 ；2. 南通大学附属南通第三医院，南通市第三人民医院消化科，江苏 南通 226006 |
| |
| 基金项目： | 南通市市级科技计划项目（JCZ18046）；南通市卫生和计划生育委员会科研课题专项（MA2019010，MB2020031）。 |
| |
| 摘 要： | 背景与目的:程序性死亡[蛋白]-1(programmed death-1,PD-1)在调节外周免疫耐受中发挥重要作用,PD-1在肝细胞癌(hepatocellular carcinoma,HCC)肿瘤浸润淋巴细胞中的表达状态与效应细胞CD8+T淋巴细胞的关系尚不清楚,探讨HCC肿瘤浸润淋巴细胞中PD-1的表达及预后意义...
|
| 关 键 词： | 程序性死亡[蛋白]-1 程序性死亡[蛋白]配体-1 肝细胞癌 预后 |
The expression of programmed death 1 in tumor-infiltrating lymphocytes of hepatocellular carcinoma and its correlation with prognosis |
| |
| XIAO Feng,XIAO Jingwen,SHAO Jianguo,CHEN Liyan,GU Chunyan. The expression of programmed death 1 in tumor-infiltrating lymphocytes of hepatocellular carcinoma and its correlation with prognosis[J]. China Oncology, 2021, 31(5): 419-427. DOI: 10.19401/j.cnki.1007-3639.2021.05.008 |
| |
| Authors: | XIAO Feng XIAO Jingwen SHAO Jianguo CHEN Liyan GU Chunyan |
| |
| Affiliation: | 1. Department of Pathology, the Third People’s Hospital of Nantong, Affiliated Nantong Third Hospital of Nantong University, Nantong 226006, Jiangsu Province, China; 2. Department of Gastroenterology, the Third People’s Hospital of Nantong, Affiliated Nantong Third Hospital of Nantong University, Nantong 226006, Jiangsu Province, China; |
| |
| Abstract: | Background and purpose: Programmed death 1 (PD-1) plays an important role in the regulation of peripheral immune tolerance. The expression of PD-1 in tumor-infiltrating lymphocytes of hepatocellular carcinoma (HCC) and the relationship between PD-1 expression and CD8 + T lymphocytes is unclear. This study was aimed to investigate the expression of PD-1 in tumor-infiltrating lymphocytes of HCC and its prognostic significance. Methods: Pathological paraffin samples of 344 HCC patients who underwent surgery in Nantong Third People’s Hospital from January 2008 to December 2016 were included. Tissue microarray was prepared. The protein expressions of PD-1 and programmed death ligand-1 (PD-L1) in HCC tissues were detected by immunohistochemical assay. Statistical analysis was performed to determine the correlation between the expression of PD-1 in tumor-infiltrating lymphocytes and the clinicopathological parameters of HCC, the expression of PD-L1, CD8 + T lymphocytes andthe prognosis of patients. The influence of CD8 + PD-1 + double expression T lymphocyte density on the prognosis of HCC patients was detected by immunohistochemical double labeling. Results: PD-1 positive signal was localized on the membrane or cytoplasm of HCC tumor-infiltrating lymphocytes. The high expression rate of PD-1 was 43.9%, which was related to tumor histological grade (P=0.009), tumor cell PD-L1 expression (P<0.001), tumor-infiltrating lymphocytes PD-L1 expression (P<0.001) and tumor infiltrating CD8 + T lymphocyte density (P=0.003). Moreover, PD-1 overexpression was an independent risk factor for evaluating the overall survival (OS) rate and the disease-free survival (DFS) rate (OS: HR=1.654, P=0.010; DFS: HR=2.518, P<0.001). In addition, patients with high-density tumor-infiltrating CD8 + PD-1 + double expression T-lymphocytes had worse OS and DFS compared with those with low-density tumor (P<0.001). Conclusion: The expression of PD-1 in tumor-infiltrating lymphocytes of HCC may be a potential prognostic factor. |
| |
| Keywords: | Programmed death 1 Programmed death ligand-1 Hepatocellular carcinoma Prognosis |
|
| 点击此处可从《中国癌症杂志》浏览原始摘要信息 |
|
点击此处可从《中国癌症杂志》下载全文 |
|
